DT treatment significantly reduced tumor burden in MMDTR TB mice compared to C57BL/6 TB mice (Fig. 6b), indicating that CD115+ M-MDSCs and the descendant cells contribute to tumor progression. This evidence concerns the gene CSF1R and neoplasm.